Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120834683 | 12083468 | 3 | F | 201601 | 20160802 | 20160217 | 20160810 | EXP | FR-ASTRAZENECA-2016SE15679 | ASTRAZENECA | 1033.00 | MON | M | Y | 59.00000 | KG | 20160810 | MD | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120834683 | 12083468 | 1 | PS | INEXIUM | ESOMEPRAZOLE | 1 | Oral | 3680 | MG | Y | 0 | 40 | MG | QD | |||||
| 120834683 | 12083468 | 2 | SS | CORDARONE | AMIODARONE HYDROCHLORIDE | 1 | Oral | Y | 0 | 200 | MG | ||||||||
| 120834683 | 12083468 | 3 | SS | TAHOR | ATORVASTATIN CALCIUM | 1 | Oral | 920 | MG | Y | 0 | 10 | MG | QD | |||||
| 120834683 | 12083468 | 4 | SS | MIANSERINE | MIANSERIN HYDROCHLORIDE | 1 | Unknown | 1.0DF UNKNOWN | Y | 0 | 1 | DF | |||||||
| 120834683 | 12083468 | 5 | C | AMLOR | AMLODIPINE BESYLATE | 1 | Oral | 0 | 10 | MG | QD | ||||||||
| 120834683 | 12083468 | 6 | C | CALCIDIA | CALCIUM POLYCARBOPHIL | 1 | Oral | 0 | 3.08 | MG | QD | ||||||||
| 120834683 | 12083468 | 7 | C | DIAMOX SEQUELS | ACETAZOLAMIDE | 1 | Oral | 0 | 750 | MG | QD | ||||||||
| 120834683 | 12083468 | 8 | C | DIFFU K | POTASSIUM CHLORIDE | 1 | Oral | 0 | 1200 | MG | TID | ||||||||
| 120834683 | 12083468 | 9 | C | NOVOMIX FLEXPEN | INSULIN ASPART | 1 | Subcutaneous | 0 | 2 | IU | QD | ||||||||
| 120834683 | 12083468 | 10 | C | NOVOMIX FLEXPEN | INSULIN ASPART | 1 | Subcutaneous | 0 | 16 | IU | QD | ||||||||
| 120834683 | 12083468 | 11 | C | NOVORAPID | INSULIN ASPART | 1 | Subcutaneous | 0 | 6 | IU | QD | ||||||||
| 120834683 | 12083468 | 12 | C | KARDEGIC | ASPIRIN LYSINE | 1 | Oral | 0 | 75 | MG | QD | ||||||||
| 120834683 | 12083468 | 13 | C | LASILIX SPECIAL | FUROSEMIDE | 1 | Oral | 0 | 500 | MG | BID | ||||||||
| 120834683 | 12083468 | 14 | C | MOVICOL | POLYETHYLENE GLYCOL 3350POTASSIUM CHLORIDESODIUM BICARBONATESODIUM CHLORIDE | 1 | Oral | 0 | 1 | DF | QD | ||||||||
| 120834683 | 12083468 | 15 | C | RENVELA | SEVELAMER CARBONATE | 1 | Oral | 0 | 2.4 | G | BID | ||||||||
| 120834683 | 12083468 | 16 | C | UVEDOSE | CHOLECALCIFEROL | 1 | Oral | 0 | 1 | DF | /month |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 120834683 | 12083468 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 120834683 | 12083468 | Cholestasis | |
| 120834683 | 12083468 | Hepatocellular injury |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 120834683 | 12083468 | 1 | 20151029 | 20160117 | 0 | |
| 120834683 | 12083468 | 2 | 20151029 | 20160117 | 0 | |
| 120834683 | 12083468 | 3 | 20151029 | 20160117 | 0 | |
| 120834683 | 12083468 | 4 | 20160115 | 0 | ||
| 120834683 | 12083468 | 5 | 20151029 | 0 | ||
| 120834683 | 12083468 | 6 | 20151029 | 0 | ||
| 120834683 | 12083468 | 7 | 20151116 | 20160119 | 0 | |
| 120834683 | 12083468 | 8 | 20151029 | 20160119 | 0 | |
| 120834683 | 12083468 | 9 | 20151116 | 0 | ||
| 120834683 | 12083468 | 10 | 20151116 | 0 | ||
| 120834683 | 12083468 | 11 | 20151116 | 0 | ||
| 120834683 | 12083468 | 12 | 20151029 | 0 | ||
| 120834683 | 12083468 | 13 | 20151116 | 20160126 | 0 | |
| 120834683 | 12083468 | 14 | 20151029 | 0 | ||
| 120834683 | 12083468 | 15 | 20151029 | 20160126 | 0 |